Tocilizumab treatment in COVID‐19: A single center experience
Abstract Tocilizumab (TCZ), a monoclonal antibody against interleukin‐6 (IL‐6), emerged as an alternative treatment for COVID‐19 patients with a risk of cytokine storms recently...
Abstract Tocilizumab (TCZ), a monoclonal antibody against interleukin‐6 (IL‐6), emerged as an alternative treatment for COVID‐19 patients with a risk of cytokine storms recently...
Objective To analyze trends in hypertension, diabetes, and dyslipidemia prevalence among Chinese offshore oil workers and explore the independent and interaction effects of age ...
h-index: Number of publications with at least h citations each.